Advertisement

Topics

Latest Biotechnology, Pharmaceutical and Healthcare News from ecancermedicalscience

07:23 EDT 18th October 2017 | BioPortfolio

Here are the most relevant search results for "ecancermedicalscience" found in our extensive news archives from over 250 global news sources.

More Information about ecancermedicalscience on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about ecancermedicalscience for you to read. Along with our medical data and news we also list ecancermedicalscience Clinical Trials, which are updated daily. BioPortfolio also has a large database of ecancermedicalscience Companies for you to search.

Showing News Articles 1–25 of 1,200+ from ecancermedicalscience

Wednesday 18th October 2017

Drug yields high response rates for lung cancer patients with harsh mutation

A targeted therapy resurrected by the Moon Shots Program™ at The University of Texas MD Anderson Cancer Center has produced unprecedented response rates among patients with metastatic non-small cell lung cancer that carries a highly treatment-resistant...

Proposed lung cancer resection status between R0 and R1 affirmed

The findings of a recent study confirm the International Association for the Study of Lung Cancer (IASLC)'s proposed criteria for uncertain resection margin status, R(un), in residual tumour (R) classification. Dr. John Edwards of the University of...

Treatment based on BRCA1 level does not increase survival of stage II/III NSCLC resected patients

New research shows that treating stage II and III non-small cell lung cancer (NSCLC) N resected patients with customized chemotherapy (CT) treatment based on their specific BRCA1 expression levels, as opposed to providing the standard treatment, did not...

Tuesday 17th October 2017

New bowel cancer drug target discovered

Researchers at the Francis Crick Institute have discovered a new drug target for bowel cancer that is specific to tumour cells and therefore less toxic than conventional therapies. "There has long been a need to find more effective and less toxic drugs...

Timing of melanoma diagnosis, treatment critical to survival

A new study underscores the importance of early detection and treatment of melanoma, the deadliest form of skin cancer. The research, published online in the Journal of the American Academy of Dermatology, indicates that the sooner patients were treated,...

The first ‘complete guide’ on scalp cooling published

Academics from the University of Huddersfield, UK, have published the first ‘complete guide’ on scalp cooling which aims to be a major point of reference for clinical staff. The review article published in The Oncologist includes the most relevant...

Many pelvic tumours in women may have common origin in fallopian tubes

Most - and possibly all - ovarian cancers start, not in ovaries, but instead in the fallopian tubes attached to them. This is the finding of a multicenter study of ovarian cancer genetics led by researchers from Perlmutter Cancer Center at NYU Langone...

Scientists identify biomarker for progression and drug response in brain cancer

Scientists at the Icahn School of Medicine at Mount Sinai, Sema4, and collaborating institutions including Colorado State University and Fred Hutchinson Cancer Center reported results from a glioblastoma study in which they validated a biomarker...

Novel mechanism of resistance to anti-cancer drugs

The targeted anti-cancer therapies cetuximab and panitumumab are mainstays of treatment for advanced colorectal cancer, the second leading cause of cancer-related deaths in the United States. However, many patients have tumours with genetic mutations...

Biology of childhood brain tumour subtypes offers clues to precision treatments

Researchers investigating paediatric low-grade gliomas (PLGG), the most common type of brain tumour in children, have discovered key biological differences in how mutated genes combine with other genes to drive this childhood cancer. By shedding light on...

Monday 16th October 2017

Researchers show the potential of precision medicine for treating rare cancers

For the first time, researchers have been able to identify effective treatments for patients with rare cancers by analysing genes and proteins in their blood and tumours. In a study reported in The Oncologist, half the patients receiving these targeted...

Bolstering fat cells offers potential new leukemia treatment

Killing cancer cells indirectly by powering up fat cells in the bone marrow could help acute myeloid leukaemia patients, according to a new study from McMaster University. Researchers with the McMaster Stem Cell and Cancer Research Institute found that...

Fulvestrant receives positive CHMP opinion with palbociclib for HR positive advanced breast cancer

The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending a new indication for fulvestrant that will expand its use to include combination therapy with palbociclib. The...

Sunday 15th October 2017

Cancer relapse linked to body’s own immune system

Cancer cells that survive after treatment may use the body’s own immune system to wake themselves up and fuel their growth, a new study shows. The research sheds new light on how the immune system loses its ability to keep cancer in check, leading to...

Friday 13th October 2017

CHMP issues positive opinion on abiraterone acetate to include earlier prostate cancer

The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended broadening the existing marketing authorisation for abiraterone acetate plus prednisone / prednisolone to include an earlier stage of prostate...

CHMP issues positive opinion on abieraterone acetate to include earlier prostate cancer

The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended broadening the existing marketing authorisation for abiraterone acetate plus prednisone / prednisolone to include an earlier stage of prostate...

E-cigarettes safer as a smoking subsitute, but not without risk

by ecancer reporter Will Davies Across many countries, smoking rates have plummeted in the last two decades. This has come due to social and legal efforts, including indoor and public smoking bans, public health awareness campaigns, and higher prices,...

Exploring how games can help children cope with cancer – new pilot from iManageCancer

The iManageCancer project, of which ecancer is a member, has the goal of improving the lives of people living with chronic illnesses like cancer by harnessing the power of mobile phone technology, and helping those with cancer take control of their...

Nivolumab made available for head and neck cancers on the Cancer Drugs Fund

The immunotherapy nivolumab has today been made available on the Cancer Drugs Fund (CDF) for patients with head and neck cancer if the disease progresses within six months of receiving platinum chemotherapy. Professor Kevin Harrington, who is Professor...

Vitamin C regulates stem cell function and risk of leukaemia

by ecancer reporter Janet Fricker Ascorbate (Vitamin C) regulates the function of stem cells and suppresses development of leukaemia, finds a study published in Nature. In western countries, plasma ascorbate levels vary 10-fold among individuals, with...

Researchers find a potentially better way to treat liver cancer

A Keck School of Medicine of USC research team has identified how cancer stem cells survive. This finding may one day lead to new therapies for liver cancer, one of the few cancers in the United States with an incidence rate that continues to...

Thursday 12th October 2017

Scientists pinpoint surprising origin of melanoma

Led by Jean-Christophe Marine (VIB-KU Leuven), a team of researchers has tracked down the cellular origin of cutaneous melanoma, the deadliest form of skin cancer. The team was surprised to observe that these very aggressive tumours arise from mature,...

Halting liver cancer with a sugar substitute

Researchers at the RIKEN Global Research Cluster in Japan have discovered a way to prevent the spread of cancer in the liver. Published in the journal Cell Chemical Biology, the study details how treatment with a modified fucose sugar can disrupt a...

Biomarker for guiding prostate cancer treatment revealed

Back-to-back discoveries from Cleveland Clinic demonstrate for the first time how a testosterone-related genetic abnormality can help predict individual patient responses to specific prostate cancer therapies. The studies, published in the October 12...

Immune response to ovarian cancer may predict survival

A group of international cancer researchers led by investigators from Mayo Clinic and University of New South Wales Sydney has found that the level of a type of white blood cell, called tumour-infiltrating lymphocytes, present in the tumours of patients...


Quick Search
Advertisement
 

News Quicklinks